Skip to main content
SpringerLink
Log in

Tocilizumab/hydroxychloroquine/prednisolone

First report of Lyme borreliosis with unusual rapid progression: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tabor D, et al. Lyme borreliosis in a patient on tocilizumab: A case report. British Journal of Dermatology 175 (Suppl. S1): 154-155 abstr. BI22, Jul 2016. Available from: URL: http://doi.org/10.1111/bjd.14581 [abstract] - United Kingdom

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tocilizumab/hydroxychloroquine/prednisolone. Reactions Weekly 1635, 289 (2017). https://doi.org/10.1007/s40278-017-25538-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-25538-1

Search

Navigation